Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Pharmacoepidemiology Meeting 2018

About Conference


Conference Series Ltd is delighted to extend our warm welcome to you all to participate in the Pharmacoepidemiology 2018, September 24-25, 2018 at Dubai, UAE .
 
Why to Attend???
 
Pharmacoepidemiology 2018, September24-25, 2018 at Dubai, UAE is organised aiming to bring together leading academic professors, scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacoepidemiology . It also provides a premier interdisciplinary pavement  for Pharma, Biotech and Medical Device industries and to represent their company and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacoepidemiology and Clinical trials and clinical research.
 
Pharma-epidemiology congress includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and extensive networking and B2B interactions.
 
ConferenceSeries Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals  which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.
 
Mark your dates to join the critical discussions and meet the experts at Pharma-epidemiology congress, Kuala Lumpur, Malaysia to enleash Advanced Clinical research and compliance in Pharmacoepidemiologic studies in the arena of Pharmacoepidemiology.
 
Who Should Attend ???
 
Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of
 
CROs and CMOs
Clinical Research Sites
Pharma/Biotech and Medical Device industries
Hospitals, Associations
Medical Directors, Principal Investigators, Methodologists, and other clinical research professionals along with Academicians: University Faculties like Directors, Senior Professors/Assistant Professors/ Associate Professor, Research Scholars, scientists who are related to clinical and medical research.
 
Clinical/Pharmaceutical and biotech industry professionals with responsibilities in:
 
Clinical Research & Development 
Clinical Design/ Protocol Design/ Clinical Strategy
Global Clinical Operations/ Clinical Outsourcing 
Biostatistics/Data management
Patient Recruitment/Enrollment 
Clinical Trial Management/Clinical Trial Supplies
Regulatory Affairs

Sessions/Tracks

Conference Series Ltd is delighted to extend our warm welcome to you all to participate in the Pharmacoepidemiology 2018, scheduled at Dubai, UAE during September 24-25, 2018.
 
Experts Meeting to join the Global scientific influencers from  Asia, Middleeast, Europe, USA(America) and Africa at Pharmacoepidemiology and Clinical research Congress, organised at Dubai, UAE during September 24-25, 2018.
 
Pharmacoepidemiology Meeting includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and extensive networking and B2B interactions.
 

Track 1: Pharmacoepidemiology

 
Pharmacoepidemiology is an extensive area of science which involves uses and effects of drugs in larger arena of population. Pharmacoepidemiology is a bridge of science which connects both pharmacology and epidemiology enhancing the informative study on topics apparently related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety, Pharmacovigilance, effects of genetic variation on drug effect, duration-response relationships, clinical effects of drug-drug interactions. This topic serves as a best way for Researchers to express their findings as research presentations on an array of Pharmacoepidemiology and Drug Safety. The main aim of Pharmacoepidemiology within the industry is to protect patients from unnecessary medication hazards by identifying the adverse effects, elucidating pre-disposing factors, refuting false safety signals and quantifying risk in relation to benefit.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 

Related Associations or Societies:

 
 
Pharmacotherapy also known as drug therapy is the use of a medical therapies (Surgical, Chemotherapy, Physical therapy, Radiation therapy) to treat disease. Drugs interact with receptors or enzymes present in cells, which promote healthy functioning and shave or cure illness. Drug Safety refers to the pharmacological science that ensures safety and is related to the collection, detection, assessment, monitoring, and prevention of adverse drug effects with pharmaceutical products. Safety monitoring in clinical trials involves the collection of adverse events, laboratory investigations including the planning, execution, data analysis and reporting of the safety information and details of the clinical examination of patients.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 

Related Associations or Societies:

 
Track 3: Action of Drugs :
 
Action of Drugs also known Pharmacodynamics. It refers to the study of Drugs, its biochemical, physiologic effects, the mechanisms and its action on the body or on microorganisms and other parasites within or on the body. It deals with drug action, which is the initial consequence of a drug-receptor interaction, and drug effect, which refers to the subsequent effects. The drug action of digoxin, for example: The inhibition of membrane Na+/K+-ATPase; the drug effect is augmentation of cardiac contractility. In this example, the clinical response may comprise of improved exercise tolerance.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 

Related Associations or Societies:

 
 
Track 4: Clinical Research:
 
Clinical research  is the branch of science that involves the use of various medications, clinical therapeutics, medical and clinical devices, equipment and medical products for diagnosis and treatment of human disorders, diseases and patient safety.
 
Related Pharmacoepidemiology Congresses | Clinical Research Meetings | Drug Safety events
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 

Related Associations or Societies:

 
 
Track 5:Clinical Trials:
 
Clinical trials describe the distinct procedures followed in development of new drugs. These are the characteristic studies intended for the treatment of behavioural symptoms among the medical intervention and a health outcome. Clinical trials comprise patient data, disease mechanisms, therapeutic interventions, epidemiology, clinical medicine, preclinical and clinical pharmacology, immunology, toxicological studies. Clinical trials consist of experimental clinical trials scrutinizes the new treatment replacing the placebo or existing alternative treatments and  safety methodology using data from observation of patients treated in clinical. Clinical data is the key feature translating basic research into medical care. The perfect conclusion of clinical trials is minimize risks, extend benefits and optimal use of an intervention of therapeutic drugs .
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 

Related Associations or Societies:

 
Track 6: Pharmacology:
 
Pharmacology  is the study of interaction between substances with living organisms to produce a change in function. It deals with the research, discovery, and characterization of chemicals that show biological effects and the illumination of cellular and organism function in relation to these chemicals. If substances have medicinal properties, they are defined as pharmaceuticals. The Pharmacology encompasses mechanisms of drug action, drug composition and properties, interactions, toxicology, therapies, medical applications, and anti pathogenic capabilities.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 
Related Associations or Societies:
 
 
 
Genetic epidemiology refers to “the role of genetic factors and genetic variations for determining health, disease in families and in populations and the interplay of such genetic factors with environmental factors. Genetic epidemiology seeks to derive a statistical and quantitative analysis of how genetics work in huge groups.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 
Related Associations or Societies:
 
 
 
Databases contain professional assessment of the potential of drugs and permit the risk- profit analysis of medicinal products taking under consideration new and emerging information, within the context of additive data. These databases offer programming of alerts for fast cases, follow-up cases and reports submission to fulfil regulative timeline compliance. Data sources of pharmacoepidemiological databases are CPRD (Clinical Practice Research Data link), IMS Health Disease Analyser databases, PHARMO, Vigibase and Eudravigilance. Pharmacoepidemiology research studies may involve either data collected prospectively for the purpose of the particular study i.e. primary data, or data that were already collected for another purpose – as part of administrative records or patient health care , which is called secondary data.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 
Related Associations or Societies:
 
 
 
Clinical Pharmacy and Pharmacy Practice involves developing the professional roles of pharmacists and is the order of drug store which includes adding to the expert parts of drug specialists. It includes Disease-state management, Clinical drug interventions, Pharmacy professional development and pharmaceutical care, pharmaceutical compounding and health psychology, patient care, drug abuse prevention, prevention of drug interactions or minimisation of adverse events and drug incompatibility and community pharmacy.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 
Related Associations or Societies:
 
 
 
Pharmacovigilance plays a key role in all phases of clinical trials, including the planning, execution, data analysis and reporting of safety information and also bears an important responsibility for the expedited reporting of individual cases and safety updates required for regulatory authorities. The concept of Pharmacovigilance and its Significance enhances the impact of healthcare management on patient welfare and public health. Pharmacovigilance legislation gives an outlook on the rules and regulations to follow in Pharmacovigilance practice. The Role of Pharma industries in the improvement of Pharmacovigilance system is very crucial to maintain the safety data, detection and evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Eco Pharmacovigilance (EPV), Pharmacoenvironmentology and Pharmacovigilance in herbal medicines. In addition, data from observational epidemiological studies are playing an increasingly important role.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 
Related Associations or Societies:
 
 
Track 11: Risk Management:
 
Pharma Risk Management was designed as a set of Pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks of medicinal and therapeutic products including the assessment of the effectiveness of their clinical reactions, interventions and combination therapies. Drug industry need to promote companies in Pharmacovigilance practice to use information technology and provide efficient software to implement the risk minimisation plans in drug development and manufacture. Pharmaceutical risk management monitors unlicensed, off labels and orphan drugs ,risk management labelling, regulatory decisions, legal protection, intellectual property, enforcement, marketing, and company reputation.
 
 
12th International Conference on Pharmacoepidemiology and Clinical Research, October17-18,2018,Seoul,South Korea;12th Global Pharmacovigilance & Drug Safety Summit, July 9-10, 2018 Sydney, Australia; 9th World Congress on Bioavailability & Bioequivalence,March 19-21, 2018 Dubai,UAE; 5th Annual Congress on Chemistry in Drug Discovery & Designing ,April 16-17, 2018 Dubai ,UAE, 2nd World Heart Congress    May 14-16, 20178 Tokyo Japan; 9th Asian Biosimilars Congress August 20-22, 2018 Tokyo Japan .
 
Related Associations or Societies:
 
 

To Collaborate Scientific Professionals around the World

Conference Date September 24-25, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Advances in Pharmacoepidemiology & Drug Safety Journal of Clinical Research & Bioethics Journal of Clinical Trials

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos